压力导丝应用于冠心病介入诊疗中的价值

Value of Pressure Guide Wire in Interventional Diagnosis and Treatment of Coronary Heart Disease

目的探讨压力导丝应用于冠心病介入诊疗中的价值。方法选取2017年5月至2018年6月于大连市中心医院就诊的100例冠心病患者作为研究对象,随机将其分为观察组和对照组,每组50例。对照组采用常规护理,观察组在对照组基础上按照临床医学经验及冠状动脉血流储备指导应用压力导丝进行介入诊疗。比较两组病变数量、支架植入个数、住院费用及6个月内主要心血管不良事件发生情况。结果观察组患者支架植入个数明显少于对照组,差异有统计学意义(P<0.05)。观察组住院费用远低于对照组,差异有统计学意义(P<0.05)。两组平均病变数量及6个月内主要心血管不良事件发生率比较,差异均无统计学意义(均P>0.05)。结论将压力导丝应用于冠心病患者介入诊疗中,能有效避免不必要的支架植入,减少患者医疗开销,且不会增加主要心血管不良事件。

Objective To investigate the value of pressure guide wire in interventional diagnosis and treatment of coronary heart disease.Methods A total of 100 patients with coronary heart disease who were treated at Dalian Central Hospital from May 2017 to June 2018 were selected as the research objects,and they were randomly divided into observation group and control group,with 50 cases in each group.The control group received routine nursing care,and the observation group used pressure guidewire for interventional diagnosis and treatment based on clinical medical experience and coronary blood flow reserve guidance on the basis of the control group.The number of lesions,the number of stents,hospitalization expenses,and the occurrence of major adverse cardiovascular events within 6 months were compared between the two groups.Results The number of stents implanted in the observation group was significantly less than that in the control group,and the difference was statistically significant(P<0.05).The hospitalization expenses of the observation group were much lower than those of the control group,the difference was statistically significant(P<0.05).There was no statistically significant difference in the average number of lesions and the incidence of major cardiovascular adverse events within 6 months between the two groups(all P>0.05).Conclusion The use of pressure guide wire in interventional diagnosis and treatment of patients with coronary heart disease can effectively avoid unnecessary stent implantation,reduce patient medical expenses,and will not increase major cardiovascular adverse events.